Roche Holding AG 2024 AR2
The report outlines Roche's sustainability performance and strategic progress in 2024. Key highlights include the submission of near- and long-term emissions reduction targets to the Science Based Targets initiative, aiming for net-zero value chain emissions by 2045 and absolute zero Scope 1 and 2 emissions by 2050. The company also expanded healthcare access, screening over 300,000 women for cervical and breast cancer in Kenya through the EMPOWER 2.0 initiative. Additionally, Roche advanced diversity, equity, and inclusion, achieving a 0.5% increase of women in executive positions and investing USD 1.4 billion in diverse suppliers in the US.
Company: Roche Holding AG
Sector: Manufacturing
Country: Switzerland
Year: 2024
Type: AR2
Pages: 216
Roche Holding AG
The report outlines Roche's sustainability performance and strategic progress in 2024. Key highlights include the submission of near- and long-term emissions reduction targets to the Science Based Targets initiative, aiming for net-zero value chain emissions by 2045 and absolute zero Scope 1 and 2 emissions by 2050. The company also expanded healthcare access, screening over 300,000 women for cervical and breast cancer in Kenya through the EMPOWER 2.0 initiative. Additionally, Roche advanced diversity, equity, and inclusion, achieving a 0.5% increase of women in executive positions and investing USD 1.4 billion in diverse suppliers in the US.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Water Consumption
Women in Management
Net Zero Target
Employees